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Malignant melanoma usually presents as a primary cutaneous malignancy [1,2]. It is a malignant skin tumor derived from the melanocytes. It is highly malignant due 
to its rapid growth and early metastasis. Approximately 160,000 new 
cases of malignant melanoma are diagnosed annually worldwide [3]. 
Apart from the skin, it also arises in other organs and tissues including 
the oral cavity, paranasal sinuses, esophagus, larynx, vagina, and 
anorectal region [4]. Approximately 5% of all malignant melanomas 
originate from primarily non-cutaneous sites [5].
Malignant melanoma of the breast tissue has diversified 
manifestations and can present as primary cutaneous melanoma, 
primary glandular melanoma, metastatic melanoma, and in-transit 
metastases to the breast [6]. Primary malignant melanoma of the 
breast (PMMB) is a very rare clinical condition accounting for 
3%–5% of all melanomas and for <0.5% of malignant breast 
carcinomas. The PMMB may arise from the cutaneous aspect of 
the breast or from breast parenchyma. <200 cases of PMMB are 
reported till date, based on literature search [7]. Here, we report 
one such rare case of malignant melanoma with breast as its 
primary site in a 43-year-old female.
CASE REPORT
A 43-year-old female patient presented with a hard, non-tender 
lump in her left breast for 6 months, along with redness with no 
discharge from the nipple. Her medical history was not significant, 
and her family history was non-contributory. On examination, 
the patient was vitally stable, pulse 88, blood pressure of 
120/70 mmHg, and respiratory rate 16. Local examination of the 
breast revealed a hard lump in her left breast with inflamed but 
intact skin and normal nipple and areola (Fig. 1).
On investigation, the breast ultrasound showed a solid, 
heterogeneous mass (lesion) measuring 7 cm × 4 cm in the upper 
outer quadrant at 2–3 O’clock position in the left breast with 
minimal central vascularity, nipple, and both the axillae and the 
right breast appeared normal.
Fine-needle aspiration cytology of the lump showed the 
presence of scattered and poorly differentiated malignant cells, 
suggestive of malignant melanoma; hence, core biopsy of the 
lump was advised. Histopathology of the core biopsy report was 
suggestive of malignant melanoma.
A positron emission tomography-computed tomography 
(PET-CT) was performed to determine baseline staging of 
the primary malignant melanoma of the left breast (PMMB). 
The scan showed local disease in the left breast with no 
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Figure 1: Surgical specimen of the breast melanoma (black arrow 
showing the nipple and white arrow showing the protruding 
melanoma)
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nodal or distant metastases. The patient underwent modified 
radical mastectomy with axillary node dissection after a 
multidisciplinary opinion. The surgical histopathological report 
stated that a well-circumscribed malignant melanoma of size 
10 cm × 10 cm × 7 cm was present, which did not involve the base, 
skin, or nipple. Tumor cells were oval, polyhedral, and fusiform 
with marked nuclear anaplasia and multiple bizarre tumor giant 
cells. 1/22 lymph nodes showed metastatic malignant melanoma 
without perinodal infiltration. Immunohistochemistry report 
revealed a vimentin-, melanosome-HMB-45-, MART-1 
MELAN-A-, and SOX-10-positive malignant melanoma that 
was focally positive for cytokeratin, European Medicines 
Agency, and S-100 (Fig. 2).
The disease was staged as per the staging guidelines for melanoma 
of the American Joint Committee on Cancer as pT4a, pN1a, and Mo, 
i.e., Stage IIIC [8]. B-RAF V600 mutation studies were negative. 
Adjuvant therapy options with nivolumab versus ipilimumab were 
discussed with the patient. However, the patient was not willing for 
any other treatment due to financial constraints. On the 4 months 
of follow-up visit, the patient presented with local and contralateral 
axillary nodal radiological recurrence, pancreatic, and lower pole of 
kidney metastases, as shown on the follow-up PET-CT.
DISCUSSION
The key diagnostic aids in the assessment of PMMB include 
pathological morphology, immunohistochemistry, and electron 
microscopy. The important diagnostic features of PMMB include 
pleomorphism of tumor cells and nuclear atypia; scattered 
intracellular pigment granules; positive expression of the proteins 
S-100, HMB-45, and melan-A on immunochemistry; electron 
microscopy findings of melanosome and former melanosome; 
changes in the edge of the tumor tissue and normal breast tissue; 
and exclusion of tumor metastases and tumor invasion from 
neighboring sites [6].
The treatment of PMMB requires special attention in view of 
the rarity of the disease and the complex anatomy of the breast. 
Evidence from the available case reports suggests that radical 
surgical resection with free margins combined with axillary 
node resection or axillary sentinel node resection constitutes the 
primary treatment of choice in PMMB patients. Mastectomy and 
Figure 2: Image of immunohistochemical (IHC) staining showing 
(a and b) Melan-A-positive malignant melanoma tumor cells; 
(c) SOX-10-positive malignant melanoma tumor cells; (d) IHC 
staining of malignant melanoma tumor cells
a b
c d
Table 1: Examination findings and treatment of PMMB case reports
Previous case reports Examination findings Treatment
A 56-year-old woman presented with mass 
in the left breast that was detected 4 months 
back. The patient also had complaints of 
shoulder pain [5]
5 cm×5 cm, firm, well-defined, and tender mass 
in the upper outer quadrant of the left breast that 
was not attached to the skin. A large lymph node 
was palpable in the left axilla
Mastectomy and axillary lymph node 
dissection and systemic chemotherapy
A 26-year-old woman presented with painless 
mass in the left breast for 3 months [6]
3 cm×2 cm firm irregular mass in the upper inner 
quadrant of the left breast. There was no change 
in the appearance of the local skin, no discharge 
from, or retraction of, the nipple. A small number 
of lymph nodes were palpated in the left axilla
The patient refused surgery and further 
treatment and succumbed after 2 months 
due to widespread metastasis
A 54-year-old woman presented with large 
palpable mass in the left breast [7]
Ultrasonography of the left breast revealed a 
homogenous, diffuse echogenic lesion in the outer 
upper quadrant with sharp borders and 10 cm in 
the largest diameter
The patient was treated with mastectomy, 
axillary sentinel lymph node excision 
after peritumoral injection of 5 ml of 99 m 
technetium-marked albumin and primary 
reconstruction
A 59-year-old woman presented with a black 
pigmented skin lesion in the right breast. She 
revealed that the lesion had appeared at birth 
but grew rapidly and bled recently [9]
The lesion was 2.0 cm×1.5 cm in size and located 
on the periareolar skin in the upper inner quadrant 
of the right breast which is not associated with 
any breast mass. The axillary lymph node was 
not palpated and there was no nipple discharge or 
retraction
The patient underwent wide local excision 
of the lesion, including removal of 
normal appearing skin and underlying 
subcutaneous tissue to provide a safety 
margin
A 46-year-old female patient presented with 
complaints of breast mass in the right breast. 
She had no other complaints [12]
Well-circumscribed nodule measuring 2 cm in 
diameter in the upper outer quadrant of the right 
breast and a palpable l. 5-cm lymph node in the 
right axilla was noted
Excision of breast lesion and axillary 
lymph node was performed
PMMB: Primary malignant melanoma of the breast
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regional dissection of the internal mammary chain are not of 
significance in the management of PMMB [9].
Adjuvant treatment strategies for PMMB usually adhere 
to treatment approach suggested by the standard melanoma 
guidelines. According to the melanoma guidelines, interferon 
alpha is considered as the standard of care in high-risk patients such 
as those with regional lymph node metastasis, deep infiltration, 
and ulceration. Although adjuvant radiotherapy improves lymph 
node field control in patients at high risk of relapse, there is not 
much improvement in overall survival. Therefore, the use of 
radiotherapy following lymphadenectomy in the treatment of 
patients at increased risk of developing lymph node and distant 
recurrence remains debatable [7-10].
Management strategies for primary advanced and recurrent 
PMMB also follow the standard melanoma guidelines and 
include treatment with immunotherapies such as ipilimumab, 
vemurafenib, and systemic chemotherapy with dacarbazine, 
temozolomide, cisplatin, and paclitaxel. Therapeutic equipotency 
in the case of cutaneous PMMB may still be considered; however, 
for cases of PMMB arising from the glandular parenchyma of the 
breast, the management remains a big challenge [11-14].
There are very few clinical case reports involving primary 
cutaneous malignant melanoma of the breast. Findings and 
treatment of few case reports similar to the current case study are 
shown in Table 1. In the present study, the first symptom that was 
noted by the patient was a painless lump in the left breast. Based 
on clinical examination, histopathological features, and results 
from immunohistochemical staining, the patient was diagnosed 
with PMMB. She was treated with surgical approach; however, 
adjuvant therapy was not administered, as she was not willing for 
the same.
CONCLUSION
PMMB is a particularly rare type of malignancy with poor prognosis. 
Early diagnosis, correct surgical resection, and comprehensive adjuvant 
therapy are crucial to achieve a better clinical outcome in these patients.
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